Diagnostics’ Role in Monitoring HIV Patient Response to Therapy
Expert guidelines for initially confirming HIV infection are changing this year, moving away from dependence upon Western blot and emphasizing more practical, rapid tests.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Expert guidelines for initially confirming HIV infection are changing this year, moving away from dependence upon Western blot and emphasizing more practical, rapid tests.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Screening for sexually transmitted diseases is bringing a hidden epidemic into the spotlight. It’s also critical to keeping tabs on antimicrobial resistance.
Read MorePosted by Jenny Lower | Jun 9, 2014 | Rapid Assays |
With quick test results come public health benefits and better treatment, but for some rapid diagnostic tests, accuracy remains elusive.
Read MorePosted by Jenny Lower | Apr 17, 2014 | Cancer |
Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read MorePosted by Steve Halasey | Apr 7, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, Sexually Transmitted Diseases |
Chembio Diagnostics has announced plans to build a US sales and marketing team after notifying Alere of the termination of its US Stat-Pak distribution agreement.
Read More